From Platform to Policy: 2021 Health Care Agenda

 

With the election behind us we turn our attention to the future of health care in a new political climate.

Several polls taken right before the election showed that tackling the coronavirus was one of the top issues on voters' minds. Americans continue to be most concerned with finding solutions to diagnose, treat, prevent and ultimately end the global pandemic. While the pandemic has laid bare the inequities in our health care infrastructure, it has also created conditions favorable for innovation and an evolution in care.

Outside of the coronavirus, the other top health care issues center around protecting coverage for pre-existing conditions, health care affordability, out-of-pocket costs and the future of the Affordable Care Act.

As a new Congress convenes, how can we ensure our health system is ready for the challenges of the present and future? What policies must be enacted to address racial health disparities? How can the public and private sectors work together to promote inclusion and better health outcomes for underserved communities?

The Hill will gather policymakers, health officials and health care stakeholders for a conversation about health policy in the 117th Congress and the road ahead for America’s health care ecosystem.


Wednesday, December 9, 2020

1:00 PM ET / 10:00 AM PT

 

Speakers:

  • Senator Bill Cassidy (R-LA), Member, HELP Committee
  • Freda Lewis-Hall, Former Chief Patient Officer and Executive Vice President, Pfizer Inc.
  • Kavita Patel, Nonresident Fellow, Brookings Institution
  • Antonice Roy, Patient Perspective
  • Carl Schmid, Executive Director, HIV + Hepatitis Policy Institute
  • Rep. Lauren Underwood (D-IL), Co-Founder & Co-Chair, Black Maternal Health Caucus

 

Sponsor Perspective:

  • Stephen Ubl, President & CEO, PhRMA

 

Moderator:

  • Steve Clemons, Editor-at-Large, The Hill

 

Join the conversation! Tweet us @TheHillEvents using #TheHillHealth

 

SPONSORED CONTENT MESSAGE


Sponsored by PhRMA

America’s biopharmaceutical companies are committed to developing solutions to help diagnose, treat and prevent COVID-19, and we’re working around the clock to combat this pandemic. But our work does not stop here. We’re focused on addressing racial and health inequities, ensuring patients can afford and access the medicines they need, and working to improve health care and deliver cutting-edge innovation.